Inventor · disambiguated record
Corey Bloom
Also filed as: BLOOM COREY · BLOOM COREY J · BLOOM COREY JAY
31 granted patents·15 pending applications·380 citations·filing 2003–2025
97Inventor score
Files withDECIPHERA PHARMACEUTICALS LLC24ARRAY BIOPHARMA INC5BLOOM COREY JAY4MILLER WARREN K3GLIALOGIX INC2
Top patents by PatentIndex Score
46 records- 0198US11793795B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 24, 2023·13 cites·10 claims
- 0298US11612591B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Mar 28, 2023·31 cites·11 claims
- 0398US11576903B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Feb 14, 2023·31 cites·12 claims
- 0498US11395818B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Jul 26, 2022·36 cites·3 claims
- 0598US11185535B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Nov 30, 2021·39 cites·1 claims
- 0697US11801237B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 31, 2023·13 cites·2 claims
- 0797US8735570B2Cationic dextran polymer derivativesMILLER WARREN K·Filed 2012·Granted May 27, 2014·47 cites·16 claims
- 0895US8703204B2Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymerBLOOM COREY JAY·Filed 2008·Granted Apr 22, 2014·71 cites·15 claims
- 0995US8685458B2Pharmaceutical compositions of dextran polymer derivativesMILLER WARREN K·Filed 2010·Granted Apr 1, 2014·49 cites·18 claims
- 1094US9060938B2Pharmaceutical compositions of active agents and cationic dextran polymer derivativesMILLER WARREN K·Filed 2012·Granted Jun 23, 2015·13 cites·20 claims
- 1193US12226406B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 18, 2025·0 cites·13 claims
- 1292US12318374B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Jun 3, 2025·0 cites·24 claims
- 1392US12213968B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·18 claims
- 1492US12213967B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·11 claims
- 1592US2025387380A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 1691US12064422B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Aug 20, 2024·0 cites·20 claims
- 1790US12023328B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Jul 2, 2024·0 cites·12 claims
- 1890US11969415B1(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Apr 30, 2024·0 cites·12 claims
- 1990US11918564B1Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Mar 5, 2024·0 cites·4 claims
- 2090US11911370B1Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Feb 27, 2024·0 cites·12 claims
- 2190US11903933B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Feb 20, 2024·0 cites·15 claims
- 2290US11850240B1Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Dec 26, 2023·0 cites·3 claims
- 2390US11850241B1Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Dec 26, 2023·0 cites·12 claims
- 2489US11844788B1Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Dec 19, 2023·0 cites·12 claims
- 2587US11896585B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Feb 13, 2024·0 cites·5 claims
- 2686US9457093B2Solid dispersions of a ERB2 (HER2) inhibitorARRAY BIOPHARMA INC·Filed 2012·Granted Oct 4, 2016·14 cites·24 claims
- 2783US2024197696A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2880US8974827B2Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymerBLOOM COREY JAY·Filed 2008·Granted Mar 10, 2015·19 cites·13 claims
- 2978US2022265622A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 3078US2022265623A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 3175US9233078B2Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymerBLOOM COREY J·Filed 2008·Granted Jan 12, 2016·1 cites·16 claims
- 3274US2023097309A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3366US2021220361A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3459US2010215747A1Nanoparticles comprising ionizable, poorly water soluble cellulosic polymersBLOOM COREY JAY·Filed 2008·Application pending·0 cites
- 3559US2010266692A1Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymerBLOOM COREY JAY·Filed 2008·Application pending·0 cites
- 3659US2019275043A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3757US9757464B2Pharmaceutical compositions of dextran polymer derivativesBEND RES INC·Filed 2014·Granted Sep 12, 2017·0 cites·18 claims
- 3856US11185544B2Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using sameST IP HOLDING AG·Filed 2019·Granted Nov 30, 2021·0 cites·23 claims
- 3956US2020009118A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2019·Application pending·0 cites
- 4055US11266614B2Oral formulations of belinostatONXEO·Filed 2018·Granted Mar 8, 2022·0 cites·11 claims
- 4155US2022296589A1Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using SameST IP HOLDING AG·Filed 2021·Application pending·0 cites
- 4252US2017136022A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4351US7414359B2Low work function metal complexes and uses thereofUNIV COLORADO STATE RES FOUND·Filed 2003·Granted Aug 19, 2008·3 cites·15 claims
- 4449US2018110760A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2017·Application pending·0 cites
- 4548US2016287568A1Composition of a non-nucleoside reverse transcriptase inhibitorBAUMANN JOHN M·Filed 2014·Application pending·0 cites
- 4645US2010062073A1Pharmaceutical compositions comprising nanoparticles comprising enteric polymers caseinBEYERINCK RONALD ARTHUR·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Corey Bloom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →